Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	27,532	31,066	18,429	39,499	74,247	-
Market Cap Growth	14.98%	68.57%	-53.34%	-46.80%	-	-
Enterprise Value	22,469	26,918	13,463	34,935	70,382	-
Last Close Price	46.11	51.86	32.09	68.84	128.99	-
PE Ratio	46.77	91.35	-	27.19	60.33	-
Forward PE	31.37	11.40	11.40	25.81	50.01	-
PS Ratio	9.22	11.91	10.76	10.94	22.09	-
PB Ratio	2.54	2.89	1.92	3.89	8.31	-
P/TBV Ratio	2.66	2.97	1.98	4.00	8.54	-
P/FCF Ratio	182.64	-	-	102.30	112.63	-
P/OCF Ratio	44.70	283.83	62.12	36.64	59.81	-
EV/Sales Ratio	7.62	10.32	7.86	9.67	20.94	-
EV/EBITDA Ratio	46.55	68.22	-	22.24	44.70	-
EV/EBIT Ratio	90.00	149.52	-	25.13	49.75	-
EV/FCF Ratio	149.05	-	-	90.48	106.77	-
Debt / Equity Ratio	0	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	0.01	0.02	-	0.01	-	-
Debt / FCF Ratio	0.02	-	-	0.05	-	-
Asset Turnover	0.26	0.23	0.16	0.36	0.43	0.54
Inventory Turnover	0.84	0.96	0.68	0.70	0.64	0.55
Quick Ratio	6.62	6.77	6.05	12.65	13.14	5.66
Current Ratio	8.04	7.99	6.97	14.15	14.54	6.79
Return on Equity (ROE)	5.51%	3.35%	-4.45%	15.21%	17.08%	23.96%
Return on Assets (ROA)	1.35%	1.01%	-3.94%	8.54%	11.39%	15.50%
Return on Capital (ROIC)	1.48%	1.11%	-4.27%	9.09%	12.27%	17.05%
Return on Capital Employed (ROCE)	2.20%	1.60%	-	13.40%	15.60%	23.90%
Earnings Yield	2.11%	1.09%	-2.38%	3.68%	1.66%	-
FCF Yield	0.55%	-1.43%	-3.73%	0.98%	0.89%	-
Dividend Yield	1.08%	0.39%	-	0.44%	0.31%	-
Payout Ratio	20.36%	-	-	15.46%	16.30%	-
Buyback Yield / Dilution	-3.48%	-0.58%	-0.46%	-5.28%	-5.43%	-0.09%
Total Shareholder Return	-2.41%	-0.20%	-0.46%	-4.84%	-5.12%	-0.09%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.